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Abstract: Carbon nanotubes (CNTs) have recently been in the limelight for their potential role
in disease diagnostics and therapeutics, as well as in tissue engineering. Before these medical
applications can be realized, there is a need to address issues like opsonization, phagocytosis by
macrophages, and sequestration to the liver and spleen for eventual elimination from the body;
along with equally important issues such as aqueous solubility, dispersion, biocompatibility, and
biofunctionalization. CNTs have not been shown to be able to evade such biological obstacles,
which include their nonspecific attachments to cells and other biological components in the
bloodstream, before reaching target tissues and cells in vivo. This will eventually determine
their longevity in circulation and clearance rate from the body. This review article discusses
the current status, challenges, practical strategies, and implementations of coating CNTs with
biocompatible and opsonin-resistant moieties, rendering CNTs transparent to opsonins and
deceiving the innate immune response to make believe that the CNTs are not foreign. A holistic
approach to the development of such “stealth” CNTs is presented, which encompasses not only
several biophysicochemical factors that are not limited to surface treatment of CNTs, but also
extraneous biological factors such as the protein corona formation that inevitably controls the
in vivo fate of the particles. This review also discusses the present and potential applications,
along with the future directions, of CNTs and their hybrid-based nanotheranostic agents for
multiplex, multimodal molecular imaging and therapy, as well as in other applications, such as
drug delivery and tissue engineering.
Keywords: opsonins, macrophage, in vivo biocompatibility, near-infrared contrast nanoagents,
nanotheranostics, nanomedicine
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The last decade has seen the emergence of a new field of medicine, aptly termed
“nanomedicine”, which utilizes nanoparticles (NPs) and similar materials to diagnose and treat afflictions of the human body. It is logical that an intravenous route
will be the preferential mode of administering the NPs. Also, given that most end
capillaries are not more than 5–6 µm in diameter, it can be safely assumed that NPs
are preferred over microparticles to prevent aggregation and clogging of end vessels.
The uniqueness of NPs comes from their dimensions (ie, 1–100 nm), which are larger
than atoms and smaller than cells.1 This allows for engineered NPs to be designed in
such a way that they tag specific cells, such as tumor cells, and enable monitoring and
destruction of the respective cell type. Innovative approaches have been proposed to
design and construct NPs and their architectures with desirable size, shape and functionality, including those based on the programmable self-assembly approach.2,3 Such
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specificity and precision in targeting individual cells is an
encouraging departure from drugs that systemically target
cells (even normal cells), leading to undesired side effects.4
Furthermore, the availability of many unique NPs with their
characteristic physical, chemical, and optical properties, such
as photostable fluorescence, multiple conjugation sites for
ligands, and tunable optical responsiveness to ultraviolet, near
infrared (NIR), and infrared radiations, etc, is advantageous
for developing highly versatile targeting platforms.2,3,5,6
Research groups that have been interested in the biomedical applications of these NPs have the luxury to choose from
these signature properties to suit their individual needs, and to
tune the NPs accordingly for their desired effects. One of the
nanomaterials that attracted our attention was carbon nanotubes (CNTs), particularly single-walled CNTs (SWNTs),
which was prompted mainly due to recent revelations about
three vital traits that are required for in vivo therapeutic and
diagnostic (theranostic) purposes. One, even though there
have been mixed reports about the toxicity of CNTs, intravenous injection of adequately processed formulations in
animal models has yielded encouraging results concerning
their biocompatibility;7–13 and CNTs have demonstrated a
high degree of internalization into a wide range of cells
that could intracellularly traffic through different cellular
barriers.14–16 Two, after favorable attachment to ligands, CNTs
have shown a high degree of specificity to targeted cells and
tissues.16–19 Three, the high NIR radiation absorption and
thermal excitability of CNTs, affords minimally invasive
photothermal (PT) and photoacoustic (PA) detection, as well
as PT ablation of targeted tissue.2,16 This paved the way for
integrated nanotechnology-based therapeutics and diagnostics, also popularly known as nanotheranostics, using CNTs
and their hybrids (such as golden CNTs).2,16,17,20
Despite recent progress, several challenges must be overcome before CNTs reach their full clinical potential. Particularly,
issues like opsonization, phagocytosis by macrophages, and
sequestration to the liver and spleen for eventual elimination
from the body, should be addressed, which are major obstacles in
the translation of NPs to clinical practice (Figure 1). This review
focuses on strategies developed to coat and render CNTs transparent to nonspecific interactions with blood proteins, including
components of the immune system, in order to improve blood
circulation times and also to address biocompatibility and
specific targeting issues, which are vital to the realization of
their translation into clinical practice. While this review is not
comprehensive, we discuss the importance of “stealth”, meaning reduced uptake by the mononuclear phagocyte system, to
improve the viability of CNTs as future theranostic agents, as
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well as the physicobiochemical properties that govern imparting
of these traits. Also, we outline and analyze potential strategies
that are currently being used to impart stealth characteristics to
CNTs. Finally, we conclude with a discussion on the current
needs and future directions of this research area.

Challenges and opportunities
Nanotubes as theranostic agents
CNTs are hollow cylindrical tubes with high aspect ratios
corresponding to 100–300 nm in length for processed CNTs
and up to 2–5 µm for unprocessed CNTs, and diameters
of 1–50 nm, depending on the types of CNTs. There are
currently three known types of CNTs based on the number
of rolled layers of graphene: SWNTs with a single layer
(0.8–1.2 nm wide); double-walled CNTs (DWNTs) with two
layers (1–2 nm wide); and multi-walled CNTs (MWNTs) with
multiple concentric layers (5–50 nm wide). Ever since their
discovery in 1991,21 CNTs have attracted a lot of attention due
to their unique structure and properties. They are known to be
one of the most versatile nanomaterials around, as they exhibit
superlative electronic, electrical, optical, thermal, magnetic,
mechanical and, recently, biological properties.16,22 We will
focus on the optical, thermal, and biological properties of
CNTs since they are pertinent to the successful design and
implementation of in vivo nanotheranostic agents. SWNTs
exhibit band-gap fluorescence in the 800–1,600 nm wavelengths of the NIR spectrum.6 Photoexcitability of SWNTs in
the NIR range is of extreme significance for biological applications, since living cells and tissues are virtually transparent
to NIR radiation in the range of 750–1,200 nm.16,23 Hence, the
NIR responsiveness of SWNTs makes them ideal candidates
for bioimaging and in vivo NIR laser targeting. Besides their
ability to absorb and fluoresce NIR radiation, SWNTs act as
perfect heat accumulators, where they confine the generated
heat in its clusters, reducing heat loss to the surroundings.16,24
This critical property of SWNTs can eventually help in reducing extensive damage to the surrounding normal tissues by
localizing the heat to small pockets around itself.16,20 SWNTs
also have a high melting point of approximately 1,366 K,
which would ensure a negligible loss of structural integrity
during the PT nanotheranostics. The combined optical and
thermal properties have encouraged us to perform experiments
on bacterial and mammalian cells in vitro, accompanied by
PT and PA monitoring and PT damage using neodymiumdoped yttrium aluminum garnet (Nd:Yag) infrared laser
pulses.2,16,20,24–27 The results demonstrated the viable use of
SWNTs as not only effective targeting agents, but also as
high-affinity biomolecular interactive agents.
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Figure 1 In vivo clearance pathway of CNTs after binding to opsonins and after subsequent recognition by macrophages in the blood vessels.
Notes: The macrophages engulf the CNTs and sequester them to the hepato–biliary organs, such as the liver and spleen, for excretion. Processed short CNTs with
favorable dimension, orientation, charge, and functionalization are eliminated through the renal excretory system.
Abbreviation: CNTs, carbon nanotubes.

In addition, SWNTs possess the ability to passively
transport themselves spontaneously through the cell membrane of animal cells, as was recently shown in some in vitro
studies.14–16 This is dependent on the type, dimensions, and
nature of the CNT construction.28,29 Henceforth, SWNTs
have been demonstrated to act as transfection agents to
transport deoxyribonucleic acid (DNA), ribonucleic acid,
and other small biological moieties inside cells.17,30 The ability of SWNTs to interface with many of the biopolymers,
as well as living cells on the whole, has prompted a wide
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array of biomedical experiments.17,19,20,24–27,31–34 The most
important reason behind using CNTs as an in vivo vector
is their shape and structure. The rod-shaped CNT with its
high aspect ratio (ratio of length and diameter) provides an
ample surface area for interacting with cell surfaces, while
also affording favorable conformation to the attachment of
ligands in multiple ways (Figure 2). For example, in oxidized
SWNTs, their ends/tips with carboxyl groups (COOH) can
be used to attach certain ligands with favorable functional
groups like amines, and the hydrophobic sidewalls can be
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Figure 2 Modes of CNT functionalizations.
Notes: (A) Noncovalent functionalizations on the CNT surface are commonly achieved through hydrophobic and π-stacking interactions. (B) Covalent functionalizations
are commonly performed using 1,3-dipolar cycloaddition and oxidation by acids.
Abbreviation: CNT, carbon nanotube.

used to attach ligands with continuous conjugated systems
for π-π interactions. This allows for multifunctionalities and
for a myriad ways to design applications where such traits
are highly required.

Nanotube biofunctionalization
The architecture and surface chemistry of CNT allows
for ligands to be attached in four different ways: covalent
bonding; noncovalent hydrophobic attraction; noncovalent π-π stacking; and noncovalent electrostatic attraction
(Figure 2).35 The covalent bonding of ligands to CNT is
performed using the carboxyl functional groups that are introduced during the processing of pristine CNT, as a result of
acid-induced oxidation.36,37 The COOH groups on the CNT’s
surface can be used to form amide linkages with ligands
possessing amino groups. However, in some applications,
this chemical coupling is not favored due to the purported
effect of disrupting the electronic property of the CNT, and
also due to the indeterminate number of COOH groups that
can be introduced on the CNT, which is highly random and
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difficult to control. A given CNT can have COOH groups
introduced on its entire surface, only partially, or on the tips,
which could interfere with downstream control of ligand
attachment, potentially leading to non-uniform distribution.
For any particle that is chosen for an in vivo theranostic
application, we believe it is imperative that the coating of
ligand on its surface has to be complete and uniform, so that
the actual surface of the particle that will come in contact
with the surrounding fluids can be minimal and prevent nonspecific protein adsorption – otherwise known as a protein
corona (Figure 3).
Prevention of protein corona formation is a prerequisite
for efficient transportation, improved blood circulation halflife, and biodistribution of the particle. Noncovalent functionalization usually refers to coating the CNT with polymers
and macromolecules such as polysaccharides, whole proteins,
nucleic acids, and lipids including a combination of polymers and macromolecules as in 1,2-distearoyl-sn-glycero3-phosphoethanolamine-N-[amino(polyethylene glycol)]
conjugates (Figure 4). This strategy preserves the structural
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Transverse view

Longitudinal view

Figure 3 Protein corona formation on the CNT surface as a result of exposure to
serum proteins.
Notes: A dense and tightly-bound layer known as the hard corona is directly
formed on the CNT sidewall, and a loosely-bound layer known as the soft corona is
formed on top of the hard corona.
Abbreviation: CNT, carbon nanotube.

and electronic integrity of the CNT by associating with the
CNT surface indirectly through hydrophobic interactions.
Noncovalent hydrophobic attraction is possible between the
hydrophobic sidewalls of the CNT and hydrophobic domains
located in the ligands.25,38–41 For example, in proteins, there
are many core hydrophobic domains, which unfold and
interact with other hydrophobic materials. Polysaccharides,
such as starch, have been shown to wrap on the CNT surface
through hydrophobic interactions.40 The iodine molecule in
the starch–iodine complex undergoes displacement by the
CNT, thereby enabling the hydrophobic domains of starch to
interact with the hydrophobic sidewall of the CNT. Another
example of a hydrophobic interaction is the adsorption of
phospholipid (PL)–polyethylene glycol (PEG) moieties to
CNT.42 The two hydrocarbon chains adsorb on the CNT
sidewall, and the hydrophilic PEG groups render the CNT
water soluble and biocompatible. However, noncovalent

Small molecules

Polymers
Polysaccharides

Lipids

Proteins
Surfactants

Metals

Nucleic acids

Figure 4 Various hybrid carbon nanotube conjugates that have shown promise for
in vitro and in vivo systems.
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f unctionalization of CNT is prone to competitive adsorption
and desorption in a rich medium, such as blood, due to the
weak and transient nature of the interaction at physiological
temperatures. This can easily negate the effect of the functional groups on CNT, as the “naked” CNT is now susceptible to tagging for elimination through nonspecific protein
adsorption in the blood.
Aromatic compounds, due to their unique structure, possess π electrons that complement the π electron lattice of the
CNT. This results in π-π stacking of the aromatic rings on
the CNT sidewall without directly coming in contact with
the surface.43,44 It is CNT’s unique electronic structure that
makes such versatile bonding possible, owing to the presence of delocalized π electrons. Pyrene is one such aromatic
compound with the versatility to attach functional groups at
one terminal for conjugation with various ligands. It has been
demonstrated that proteins can be conjugated to CNT through
an amino group reactive pyrene derivative.43 The same π-π
stacking mechanism can be used to helically wrap DNA on
CNT, making them soluble in aqueous solutions, while also
enabling separation of metallic CNT from semiconducting
CNT.41 The helical isoalloxazine assembly of a low molecular
weight (MW) compound, flavin mononucleotide, hydrogen
bonds with the CNT chirality and helps in improving CNT
dispersity and aqueous solubility.45 Due to the ease of use
and control afforded by noncovalent modifications of CNT,
we have extensively used π-π stacking, as well as hydrophobic and electrostatic attraction to conjugate a wide variety
of compounds, polymers, and biomolecules on the CNT
sidewall.25,39,44 Another aspect of a noncovalent conjugation
strategy is the versatility it imparts for downstream theranostic applications such as PT therapy and PA imaging. It has
been shown that SWNT solubilized using a polymer carrying
anthracene groups and irradiated with NIR light is able to dissociate the polymer from the surface of the SWNT and cause
flocculation.46 Similarly, adsorbed species such as the chemotherapeutic drug, doxorubicin, can be desorbed from the
SWNT for release into the surrounding medium using pulsed
NIR light.47 Therefore, polymers and molecules that can be
adsorbed on the CNT surface through weak bonds, such as
through π-π stacking and hydrophobic interactions, provide
an added advantage due to the weak and facile nature of the
bond. Through this technique, highly precise and controlled
drug release mechanisms can be achieved with far-reaching
implications for nanomedicine. At the same time, caution
should be applied in thoroughly evaluating these conjugates
for their stability in various solvents and biological mediums
before using them in biomedical studies.
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Processed CNTs (ie, CNTs oxidized using acids) possess
numerous charged groups on their sidewalls, such as carboxyl
and sulfonic acid, which can be used to electrostatically bind
to other charged moieties.36 This is a conjugation scheme
that requires not only a high degree of control over the compounds used, but also optimization of the buffer solution to
prevent any cross-interactions with other charged groups in
the medium, or that are later encountered in the interacting
milieu.
It is hard to imagine that any other competing NPs
have such a varied and suitable repertoire of properties for
biomedical applications. Gold NPs, quantum dots, titanium
oxide NPs, and so on, have their own pros and cons; however,
it is CNTs’ right mix of structure, shape, and optical properties, as well as their behavior in the biological environment
that make them a frontrunner amongst contemporary NPs for
suggested biomedical applications. Despite these advantages
demonstrated by CNTs, they also possess certain inherent
disadvantages that make them difficult materials to process
and handle. CNTs have a high propensity to bundle up due
to the van der Waals attractive forces existing between the
individual tubes.48 This leads to complex entanglements
that make them very difficult to disperse in solutions. The
sp2 chemical bonding and architecture also make them
hydrophobic, thereby resulting in extremely low solubility
in aqueous solutions. It is common knowledge that all living
systems are water-based and, therefore, aqueous solubility
is a prerequisite for any potential biomedical applicability.
Converting pristine CNTs, which are manufactured and supplied as a powder form, from an extremely long, bundled,
and hydrophobic state into a shortened, individual, and
hydrophilic state will be the first challenge that investigators
usually face. Even though many strategies have been implemented to render CNTs as hydrophilic (such as treatment with
surfactants Triton™ X [Sigma-Aldrich, St Louis, MO, USA]
and sodium dodecyl sulfate), there is a need for unique and
novel solutions to make the CNTs not only water soluble,
but also biocompatible. Surfactants are usually considered to
be toxic to animal cells, as they denature the cell membrane
and eventually lead to cell disruption.49

Nanotube biocompatibility
While it is important to assess the toxicity of pristine CNTs
on vital organs and whole animals for understanding the
potential risks associated with their usage, it is equally important to carefully assess the biocompatibility of processed
and functionalized CNTs. This gains prominence given that
well-dispersed and functionalized CNTs, which are currently
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used for biomedical applications, could be eventually used
in translational studies. A wide array of cell types have been
used to characterize the cytotoxicity of CNTs, and the data
have been inconsistent and inconclusive.50–52 This is mainly
due to the lack of standard and customized techniques available to assess CNT toxicity.53 For example, use of different
cell types and diverse doses of CNTs for each study by different research groups has only led to a lack of consensus on this
issue. It has been shown that viability studies of cells incubated with CNTs and assessed using the commonly used MTT
assay (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide) yielded false positives due to the physical attraction of SWNTs with MTT–formazan crystals, thereby
interfering with the viability study.54 However, the use of its
water-soluble counterpart, WST-1 (2-[4-iodophenyl]-3-[4nitrophenyl]-5-[2,4-disulfophenyl]-2H-tetrazolium) yielded
a more plausible result as no SWNT–salt aggregations were
observed. Interestingly, use of three-dimensional cell culture
models have shown no cytotoxicity when both purified as
well as oxidized SWNTs were used, when compared to twodimensional cell cultures.55 Since three-dimensional cultures
closely represent the in vivo environment, it is assumed that
the close cell–cell interactions lead to increased population
viability and, at the same time, these adhesions prevent the
uninhibited penetration of SWNTs.55 The role of the electronic structure of CNTs on biocompatibility has also been
recently investigated. Metallic SWNTs typically have higher
reactivity than semiconducting SWNTs.56,57 Accordingly, it
was observed that cytotoxicity of metallic SWNTs was higher
on bacterial cultures when compared to semiconducting
SWNTs.58 This is attributable to increased oxidative stress
in bacteria caused by metallic SWNTs, due to increased
glutathione activity. The role of the electronic structure of
CNTs on the cytotoxicity of human cells also needs to be
investigated, given that new and improved label-free, highresolution techniques have emerged that can selectively
distinguish semiconducting SWNTs from metallic SWNTs
with submicron accuracy in living systems.59 Besides these
factors, various parameters, such as CNT surface properties
and the presence/absence of impurities, also influence cytotoxicity studies to a great extent.

Nanotube surface chemistry
Investigators have reported extensively on the adverse effects
of pristine CNTs on various organs, organ systems, and on
the general well-being of experimental animals.60–63 In cellulo
studies also suggested that the rope-like agglomerates of
unprocessed SWNTs were found to be more cytotoxic than
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well-dispersed walled nanotubes on mesothelioma (MSTO211H) cells, even more than asbestos.52 The agglomerates,
which are micron sized in diameter and length, are known
to cause inflammatory reactions such as granulomas in the
reticuloendothelial system (RES) organs such as the lungs,
liver, and spleen through a process known as “frustrated
phagocytosis”.62 This occurs when activated macrophages
unsuccessfully attempt to engulf the large agglomerates and
proceed to form granulomas – a subtype of chronic inflammation. Therefore, the need for well-dispersed CNTs for biomedical applications cannot be more overemphasized. CNTs
are capable of forming well-dispersed suspensions in aqueous
solutions after oxidation in acid solutions, mainly due to the
formation of carboxyl groups.64 Even higher degrees of aqueous solubility can be attained by functionalizing the sidewalls
with hydrophilic moieties, such as polymers. Studies on
Chinese hamster ovary cells and Jurkat human T-lymphoma
cells using glycopolymer-coated SWNTs and unfunctionalized SWNTs have demonstrated lower cytotoxicity for the
functionalized SWNTs.65 Also, unfunctionalized SWNTs
provoked the secretion of proinflammatory cytokines by
macrophages in comparison to amino group-functionalized
SWNTs.66 Some earlier studies using covalently conjugated
streptavidin-SWNTs demonstrated extensive cell death of
human promyelocytic leukemia HL60 cells after 2 days.67
In vivo studies using functionalized CNTs have shown good
biocompatibility and faster clearance rates. The degree of
chemical functionalization has proven to be the most important determinant of toxicity, with the higher degree of surface

functional groups causing lesser accumulation in the liver
and faster clearance through the renal system (Figure 5).
In a study using 99mTc-labeled MWNTs, surface carboxyl
functional groups with a density of .3 µmol/mg and lengths
,500 nm of individualized nanotubes have demonstrated
rapid clearance and low toxicity.8 Interestingly, the nature of
the functional group, carboxyl or ammonium, was not critical to the low toxicity exhibited by the highly individualized
CNT with multiple surface functional groups.13

Nanotube impurities
CNTs synthesized by both the arc–discharge process and
chemical vapor deposition contain a high degree of catalytic
impurities such as Fe, Co, and Ni.64 The cytotoxicity of these
metals is well known and well documented. It was demonstrated that rat macrophages and human A549 lung cells,
when exposed to unpurified CNTs, released reactive oxygen
species intracellularly due to cell oxidative stress.68 Other
cytotoxic effects include apoptosis; decreased adhesiveness
and inhibition of proliferation of human embryo kidney cells;
increased intracellular lipid hydroperoxides and the lowering
of low MW thiols in murine macrophages; and lower cell
proliferation rates in human epidermal keratinocytes. 69–71
However, when highly purified CNTs were incubated with
3T3 and HeLa cells, no cytotoxicity was observed.72 In
another study, when A549 cells were separately treated with
CNTs with 2% and 15% metal residues (predominantly Fe),
cells demonstrated reduced viability with 15% impurities
in comparison to those treated with 2% impurities.73 The

Hepatic clearance

Renal clearance

Hepatocytes
Podocytes

Basement membrane

Fenestrae
Fenestrae

Endothelial cells
Kupffer cell

Endothelial cells
Aligned CNT

Opsonin-coated CNT
Factors governing hepatocyte versus Kupffer cell uptake and renal clearance:
- size and shape
- surface charge
- surface property and functionalization
Figure 5 Hepatic and renal cellular ultrastructure illustrating the clearance mechanisms and physicochemical factors that contribute to effective clearance of CNTs.
Notes: Those opsonin-coated CNTs that escaped being phagocytized by macrophages in the blood are eventually recognized and internalized by resident macrophages in
the liver and Kupffer cells. Depending on certain physicochemical characteristics of CNTs, such as size and surface properties, some CNTs traverse the fenestrae in the
endothelial layer of the liver sinusoids and enter the hepatocytes for eventual excretion through the hepato–biliary–fecal route. In the kidneys, however, only shortened
CNTs with favorable charge characteristics and proper alignment can traverse the narrow (ie, 5 nm) pores.
Abbreviation: CNT, carbon nanotube.
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most commonly used method to remove the impurities
involves acid treatment of CNTs to oxidize the catalysts. As
a result of this procedure, carboxyl and hydroxyl groups are
introduced on the CNT sidewalls.64 Surprisingly, it has been
shown that purified CNTs are more cytotoxic when compared
to unpurified CNTs, as demonstrated on human intestinal
cells, Caco-2.50 This can be attributed to the carboxyl and
hydroxyl groups on the CNT surface. It can, therefore, be
reemphasized that rendering CNTs soluble in aqueous solutions does not guarantee the biocompatibility of the CNTs.
Hence, it is imperative that further functionalization of the
CNT surface is needed in order to shield the sidewall from
the surrounding environment.
Interestingly, impurities such as Fe can be used advantageously for enabling the magnetic resonance imaging
(MRI) of CNTs. Superparamagnetic iron NPs are known to
influence the relaxation time of nuclear magnetization, and
they have been used extensively as MRI contrast agents. This
was tested using high-pressure carbon monoxide (HiPCO)
SWNT with iron oxide NPs attached to one of the nanotube
tips and wrapped with DNA to assist in dispersion. The
SWNTs were internalized by macrophages and imaged in
vitro using MRI.74 In another study, pristine SWNT with
Fe impurities (10% w/w) was used for studying the in vivo
biodistribution of systemically injected SWNTs using proton
MRI imaging. A significantly higher gradient echo signal
was obtained from the spleen and kidneys for pristine SWNT
in comparison to purified SWNT.75 It is yet to be seen if
toxicologically tolerable amounts of impurities in SWNTs,
such as 2% Fe determined using in vitro assays, could permit
MRI imaging. In a following study, it was found that purified
SWNTs with 2% impurities and functionalized SWNTs with
0.7% impurities did not yield a statistically appreciable signals, thus confirming a threshold value of 10% Fe impurities
required for significant MRI contrast.76 Importantly, this study
corroborates that 2% Fe, as impurities, can be tolerated in
vivo, as no acute toxicological effect was observed in the liver
using high-resolution magic angle spinning and quantitative
real-time polymerase chain reaction analysis.

Nanotube biodistribution and biokinetics
Many pharmaceutical companies seek the development of
novel drug delivery systems to deliver the correct dose at a
specific site. The failure of traditional therapeutics in delivering precise and controlled amounts of a drug to targeted
sites has often led to severe unwanted side effects, mainly
as a result of administering excessively high doses.4 Novel
nanomaterials such as CNTs are poised to address this issue
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due to the wide variety of targeting moieties that can be
functionalized onto their surface. This new modality in therapeutics, through precision targeting, is expected to reduce
systemic side effects and improve clinical outcomes. Usually,
NP-based therapeutics are reliant on carefully selecting the
right type of NP, wherein the NP simply serves as a vector
to carry the therapeutic agent (such as antitumor drugs). To
cite a few examples, the US Food and Drug Administration
has approved some nanoparticulate and microscale drug
delivery systems: Abraxane ® (paclitaxel conjugated to
albumin particles; Celgene Corporation, Summit, NJ, USA);
AmBisome (amphotericin B liposome; Astellas Pharma US,
Inc, Northbrook, IL, USA); Myocet (doxorubicin liposome;
Enzon Pharmaceuticals, Inc, Picastaway, NJ, USA); Elestrin®
(estradiol complexed to calcium phosphate NPs; Meda
Pharmaceuticals Inc, Somerset, NJ, USA), and so on.77 The
common theme in this list of nanoparticulate formulations is
that almost all of them have the active component (the therapeutic agent) as the functionalized conjugate, and the carrier
serves only for translocating it to the target site. However,
the uniqueness of CNT stems from the fact that it can serve
not only as a vector, but also as a theranostic agent due to its
unique optical and thermal properties.
Generally, good therapeutic and clinical success can be
achieved if four important parameters can be satisfied: low
toxicity; increased blood residence time; high specificity;
and excretability. From the moment the particle is
injected intravenously until the moment it is completely
excreted, it will have to defy the natural homeostasis (it
is, understandably, an engineered “foreign” material in
the body) and perform functions autonomously. One has
to approach the selection and design of the NP with these
factors in perspective, fully understanding that each phase
is connected to the other and interdependent on each other’s
success. Surface functionalization of the CNT will aid in
improving all four parameters (Figure 4). Besides surface
functionalization, other parameters such as size and shape
could also contribute to the “harmonization” of the CNT with
the internal milieu. The good biodistribution, prolonged circulation time, blood hydrodynamics, and low clearance rate
of CNT is an essential prerequisite for its proposed biomedical applications, such as tumor targeting and drug delivery.
After intravenous injection, the CNT’s blood residence time,
organ biodistribution, and accumulation and clearance halflife are highly dependent on its surface characteristics and
coating (Figure 5).
One of the critical events that occurs immediately
after NP injection into the bloodstream is the formation
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of a biomolecular corona, also known as protein corona
(Figure 3). This is the nonspecific interfacial reaction of
blood proteins on the NP surface, which could play a decisive role in the biodistribution and biokinetics of NPs.78
Due to their high aspect ratio, CNTs can adsorb a large
number of proteins on their sidewalls through: a π-π stacking
interaction between the aromatic residues (for example, Tyr,
Phe, and Trp) and the SWNT sidewall; electrostatic interactions; and hydrogen bonding.79,80 Proteomic analysis of the
protein corona derived from human plasma adsorbed on the
PEGylated SWNT revealed up to 500 proteins, and those
derived from tissue culture media had up to 366 proteins
adsorbed on the oxidized SWNT.80,81 However, it is important to delineate “hard” coronae (ie, a tightly bound nearmonolayer of biomolecules adjacent to the NP surface) from
the “soft” coronae (ie, a more loosely associated and rapidly
exchanging layer of proteins on top of the hard coronae)
(Figure 3).78 A total of 181 proteins out of 366 constituted
the hard corona in a study that employed cell culture media.80
The hard coronae represent not only the biomolecules that
are the most abundant in the plasma and serum, which come
in contact with the NP immediately upon introduction to the
biological environment, but also quite possibly ones with the
highest affinity to the NP surface. The affinity of the proteins
to the NP surface is highly fleeting and varies depending
on the type of surface coating, density of the coating, and
charge. For example, it was determined that oxidized and
charged CNTs (ie, with COOH groups) adsorb more proteins
than pristine CNT, and the most abundant proteins are titin,
albumin, and apolipoproteins.80 Proteins, such as complement factors (C1q), even showed a preference for MWNT
over SWNT and DWNT, mainly due to their larger dimension and unique geometry.82 Using HeLa cell lysates, it was
shown that there is no strong correlation between protein
affinity to the MWNT and their relative abundance in the
medium, suggesting selectivity of the MWNT to certain proteins.81 MWNTs behave as protein magnets by attracting and
accumulating additional proteins, even after their surface is
completely saturated by a protein corona.82 This phenomenon
can be attributed to strong protein–protein interactions. It
is assumed that PEGylation of the NPs and other formulations prevents nonspecific protein adsorption in vivo. It
was, however, demonstrated that not only does PEG not
prevent protein corona formation, the pattern of adsorbed
proteins also varies with the change in PEG conformation
(Figure 6).83 When the PEG conformation transitioned from
mushroom to mushroom–brush, human fibrinogen became
more abundant than immunoglobulin (Ig)M and IgG on the
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Short linear polymer
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Figure 6 Shielding of the CNT surface using short linear, long linear, and long
branched polymers and their effect on opsonization.
Notes: Long branched polymers are able to shield the CNT surface more effectively
due to denser coverage on the CNT surface in comparison to short and long linear
polymers.
Abbreviation: CNT, carbon nanotube.

SWNT surface. This further led to shorter blood circulation
times, higher splenic versus liver accumulation, and faster
renal clearance. It can be speculated that the quantitative differences in the proteins could alter the biodistribution profile.
For example, higher IgM on SWNT could lead to preferential
uptake by the liver. Most importantly, protein corona can
also decrease the toxicity of CNTs by effectively shielding
the surface from the external milieu.79 In addition, protein
coronas might play a bigger role in CNT biokinetics in vivo,
such as assisting in cellular interactions through biomolecular
recognition, internalization, and signaling processes.84,85
The first biodistribution profiling of SWNT in mice was
performed by Wang et al,86 where hydroxylated SWNTs
were shown to be rapidly removed from circulation and
distributed evenly throughout the body. The blood clearance half-life was 49 minutes.86 Cherukuri et al87 reported
that SWNTs dispersed using Pluronic® F108 (BASF SE,
Ludwigshafen, Germany) surfactant had a blood circulation
half-life of only 1 hour, as most of the SWNTs predominantly accumulated in the liver.87 Singh et al88 demonstrated
SWNTs conjugated to a chelating agent, diethylenetriaminepentaacetic acid (DTPA), accumulated in kidneys (10.5%
injected dose [ID]), muscle (6% ID), and skin (2% ID) 30
minutes post-intravenous injection.88 The blood clearance
rate was 3.5 hours. Almost similar blood clearance rates
were observed by McDevitt et al89 on using 1,4,7,10-tetraa
zacyclododecane-1,4,7,10-tetraacetic acid (DOTA), a more
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potent chelating agent compared to DTPA, conjugated to
SWNT.89 The DOTA–SWNT conjugate accumulated in the
kidneys (8.3% ID), liver (17.8% ID), spleen (14.3% ID),
and bone (2.26% ID) 3 hours post-injection. PEGylation
of the NPs has been extensively employed to render the
xenobiotics resistant to opsonins, macrophages, and RES in
general. Currently, it is the most popular agent to prevent the
nonspecific adsorption of blood proteins in vivo. Liu et al42
reported branched PEG–PL with a MW of 2,000, 5,400, and
7,000 conjugated to SWNTs had varied blood circulation
and biodistribution profiles.42 As the degree of branching
increased from a MW of 2,000–7,000, there was an increase
in the blood circulation half-life from 0.5–7 hours. Raman
measurement on hepatic sequestration showed a decreasing
trend: 70% ID/g for 2,000 MW PEG–PL–SWNT and 30%
for 7,000 MW PEG–PL–SWNT at 24 hours post-injection.
Therefore, higher degrees of branching of PEG leads to a
more uniform and complete coating of the SWNT surface,
which leads to a higher blood circulation half-life and
delayed clearance (Figure 6). The blood residence time
of PEG did not continue to demonstrate an upward trend
beyond 7,000 MW PEG. This clearly demonstrates the need
to sheath the CNT surface from the external environment by
ensuring that most of (and if possible, the entire surface) is
coated with the functionalizing agent. Also, there is a need
for more coating materials that have PEG-like properties
to prevent opsonization and RES sequestration. This will
provide more options for investigators to coat various kinds
of xenobiotics for in vivo applications.
The dynamics of the CNT in vasculature is essential to
understand its interaction with the vessel wall, for both specific
targeting to vascular targets, as well as for the prevention of
nonspecific binding. The aspect ratio of the CNT is of particular concern, as there is speculation that it might damage
the vasculature. This can be a difficult interaction to study in
vivo. Recently, using synthetic microvascular networks, it was
shown that polystyrene nanorods demonstrate sevenfold higher
specific binding to vascular targets when labeled with targeting antibodies compared to unlabeled nanorods.90 Conversely,
only a twofold advantage in specificity was observed with
the nanospheres. Interestingly, nanorods demonstrated significantly lower nonspecific binding to the vessel wall when
compared to nanospheres. However, the binding to vascular
walls decreased as physiologically relevant hemodynamic
shear stress increased. Even though CNTs were not used for
this study, this has significant implications for all high aspect
ratio NPs concerning the interplay with their shear dynamics and their interaction with vascular walls in vivo. In vitro
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studies have shown that in the event of nonspecific binding
to vascular walls, the endothelial cells can transiently uptake
SWNTs into the acidic vesicles, while not causing any cytotoxicity. Eventually, the cells release the nanotubes into the
extracellular medium within 72 hours.91 The transient uptake
and subsequent release of the nanotubes into the bloodstream
bode well for CNT-based theranostics and, hopefully, allay any
concerns regarding damage to vasculature due to the CNT’s
high aspect ratio. However, further in vivo studies using realtime high-resolution imaging techniques, such as intravital
multiphoton microscopy, would help in better understanding
this complex interplay. Recently, SWNTs have enabled high
spatial resolution (30 µm), deeper penetration (1–3 mm),
and fast acquisition (,200 ms) imaging of vasculature in the
NIR 2 (1100–1400 nm) window that opens the door for further
investigations into vascular hemodynamics and interactions
with CNTs.92 When coupled to transient absorption microscopy, submicron resolution imaging can be achieved, which
would permit investigating real-time nano–bio interactions
with individual nanotube sensitivity.59
The liver and kidney are the two main organs involved
in the clearance of xenobiotics, while pulmonary clearance
cannot be ignored in the case of inhaled particles. In the liver,
the parenchymal cells (hepatocytes) and phagocytic Kupffer
cells represent the major pathway for clearance at the cellular
level (Figure 5). Xenobiotics taken up by hepatocytes are
eventually eliminated via bile into the feces, whereas those
taken up by Kupffer cells are retained for a prolonged period
of time and are enzymatically degraded in the phagolysosomal complex. Uptake by the hepatocytes versus Kupffer
cells is governed by factors such as size of the NP, adsorbed
opsonins on the NP surface, and charge of the NP. Typically,
particles larger than 200 nm cannot cross the fenestrations
of the liver sinusoids that drain into the parenchyma (Figure 5);93 however, well individualized CNTs could traverse the
fenestrae oriented along their long axis. It has been reported
recently that shortened and well individualized CNTs with
an average length of 200–300 nm pass through the glomerular membrane and get excreted through the renal system
(Figure 5).94,95 This is partly because the glomerular capillaries in the kidney predominantly filter based on the size of
the particles. Charge-based uptake was recently investigated
using real-time intravital multiphoton microscopy, which
revealed that negatively charged particles are taken up by
Kupffer cells, and positively charged particles are taken up
by hepatocytes.96 This was corroborated using carboxylated
MWNT in a RAW 264.7 macrophage cell line that showed
preferential uptake for oxidized MWNTs over PEGylated
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MWNTs.97 Protein corona formation inadvertently affects
specific binding of the NPs to the numerous receptors present
on the surface of the Kupffer cells (Figure 5). Since protein
corona is an inevitable outcome of systemic injection of the
NPs, it is highly likely that majority of the CNTs localize in
the Kupffer cells.78
Until a few years back, it was assumed CNTs are nonbiodegradable and would accumulate and biopersist in organs,
leading to chronic inflammation and eventually long-term
toxicity.61,62 Recent evidence points to the possibility of
addressing this issue through enzymatic degradation of the
CNT in biological systems, thereby assisting in its elimination (Figure 7). Phagocytic cells such as macrophages and,
notably, neutrophils have an abundance of myeloperoxidase
(MPO), a peroxidase enzyme that generates hypochlorous
acid and other reactive intermediates that are known to have
enough oxidizing potential to break C−C and C−H bonds
(Figure 7).98 Molecular modeling studies have revealed the
binding of SWNT to the catalytic sites of the enzyme, which
initiates the hypochlorite-mediated biodegradation of SWNT,
assisted by other reactive intermediaries.99 Other peroxidases
such as horseradish peroxidase and heme-dependent peroxidase are also capable of effectively degrading CNT.100,101
However, the effectiveness of degradation has a strong correlation to the abundance of the enzyme in respective cell
types. For example, MPO-rich neutrophils degraded 100%
of the SWNTs after 12 hours through the synergistic action
of MPO and nicotinamide adenine dinucleotide phosphate
oxidase, whereas macrophages with less abundant MPO
only degraded 13% of the SWNTs at the end of 12 hours,
which progressed to a more pronounced 50% after 48 hours

Endothelial cells

of incubation.99 An in vivo study on MPO-deficient mice
revealed that as a result of lower oxidation, the inflammatory response to SWNTs was higher than in the wild-type
mouse, which led to a lower clearance rate.102 Other phagocytic cells, such as brain microglia, have also demonstrated
partial biodegradation of MWNTs after 14 days of in vivo
stereotactic administration into the mouse motor cortex.103
The partially degraded CNT could yet be a cause for concern
not only due to its long-term proinflammatory potential, but
also because of the molecular byproducts of the degradation pathway, such as polyaromatic hydrocarbons. However,
upon administration of a partially degraded SWNT sample
into the mouse pulmonary system, there were no signs
of inflammatory markers in the pharyngeal aspirate.99 In
contrast, nondegraded SWNTs showed acute inflammatory
response accompanied by granuloma formation in the lungs.
The biodegradation of CNTs, while encouraging, should be
cautiously and thoroughly evaluated in various cell types,
including the human microbiome, and the effect of the oxidative bimolecular machinery on different types of CNTs
should be carefully assessed.
In environmentally relevant conditions, CNTs can be
biodegraded by the cooperative activity of several micro
organisms, as revealed by a study using 14C-labeled MWNT.104
Up to 6.8% of MWNT was transformed to 14CO2 over a period
of 7 days with the help of an external carbon source for
cometabolism. However, CO2 was not the only byproduct
of the degradation pathway, as other intermediaries such as
2-naphthol, 2-methoxy naphthalene, isophthalic acid, and so
on, were also generated. Importantly, it was demonstrated
that no single microorganism could efficiently degrade the
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oxida
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Figure 7 CNT biodegradation in vivo.
Notes: Circulating neutrophils expressing opsonin-binding receptors, such as Fc and complement receptors, in the blood are capable of internalizing and degrading opsonincoated CNTs. Myeloperoxidase, a peroxidase enzyme abundantly expressed in neutrophils, is capable of degrading the lattice structure of CNTs by breaking the C−C and
C−H bonds.
Abbreviation: CNT, carbon nanotube.
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MWNT. When a combination of different microorganisms
was used, there was a tenfold increase in the biodegradation
of MWNTs. This has important implications for the environment in general, as the environmental persistence of CNTs
can be attenuated. In addition, it holds important implications
for in vivo applications where the human microbiome could
play a potential role in assisting further biodegradation of
CNTs in the gastrointestinal tract and other sites with a sizeable population of microbiota. Degradation is also dependent
on the type and surface functionalization of the CNT. An in
vitro study has shown that SWNTs are oxidized and degraded
more efficiently when compared to MWNTs.105 In addition,
SWNTs with surface carboxyl groups are degraded efficiently
when compared to pristine, ozone-treated and aryl-sulfonated
SWNTs.106 A greater degree of carboxyl functionalization,
which considerably improves the hydrophilicity of the CNTs,
leads to an improved rate of degradation.107 Therefore, surface rendering of the CNTs and NPs in general for rapid and
efficient elimination is an ongoing critical investigation that
will eventually determine their potential for theranostics and,
ultimately, clinical translatability.

Need for stealth
The immune system is a defense mechanism of the human
body that acts against invading pathogens and foreign materials, and works on the basic “self/non-self ” discriminatory
rule. Anything considered harmful, including cells of the
human body, are quickly eliminated. Macrophages are
decorated with a wide arsenal of receptors hooked to the
plasma membrane: 1) receptors for complement factor
C3b; 2) receptors for the Fc portion of immunoglobulins;
and 3) receptors to mannose/fucose and other bacterial surface
polysaccharides (Figure 1).108–111 Once the pathogen/foreign
material that has already been tagged by opsonins comes in
contact with macrophages, it is rapidly recognized by the
receptors, which then initiate the phagocytic process where
the particle is engulfed by the macrophage for intracellular
digestion. Any undigested particles end up in the liver and
spleen and are eventually excreted.112 It can then be safely
agreed that CNTs would suffer the same fate as any pathogen
entering the bloodstream (Figure 1). Opsonins, C3b, and IgG,
which are present in the blood in substantial quantities, will
readily attach to the hydrophobic sidewall of the CNT, which
will tag them for macrophage recognition. Even in reports
where whole-body biodistribution studies are conducted,42,89
after amenable functionalization with ligands that prolong
blood residence times, there are high percentages of NPs
that end up in the liver and spleen because materials injected
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in bulk, in order to improve bioavailability, often aggregate
and precipitate. In such studies, the only way to effectively
monitor the location of the particles is to have a high enough
concentration to be able to trace them. Therefore, a probable
solution to improve the blood residence time is to devise
novel ways to coat the CNT with biocompatible ligands,
which prevents the attachment of opsonins to the CNT by
acting as a shield, and individually assess their performance
in vitro and in vivo. By simulating the microenvironment of
the blood vessel where such events are likely to take place, in
a matter of 1–4 hours after injection, one can determine the
behavior and fate of CNT and devise appropriate modifications to shielding if necessary. Shielding is a crucial step in
rendering the CNT transparent to opsonins and deceiving the
innate immune response to make believe it is not foreign.
The success of any diagnostic or therapeutic precision targeting system cannot be taken for granted by overlooking the
stealth mechanics of the given particle. Acquaintance with
the factors and principles that normally decide the stealth
behavior of a particle is required before we delve into the
strategies used to coat CNTs.

Physicobiochemical characteristics
governing stealth nanotube agents
Size matters
Physiological and anatomical parameters, such as blood
transport, tissue diffusion, hepatic filtration, and renal excretion, along with the size of fenestrae in the end capillaries,
dictate that the size of the particles is an important factor
that ensures prolonged circulation times and high therapeutic
efficacy for NPs.113 It was shown that in polystyrene particles,
ranging from 50–500 nm, larger particles demonstrated
higher levels of hepatic sequestration, thereby lowering their
circulation times.114 Since the emphasis is on how NPs interact with opsonins and macrophages, the radius of curvature,
which is related to size, will impact protein attachment and
subsequent macrophage interaction. It has recently been
shown that the NP size is not as important a determining
factor for phagocytosis as it was thought to be.115,116 Instead,
it was found that macrophages recognize NPs as a function
of the number of opsonins that are attached, rather than the
function of size.116 A recent study comparing SWNTs and
titanium dioxide (TiO2) NPs revealed that SWNTs adsorbed
fewer plasma proteins, even though they had a larger surface
area.117 SWNTs with a diameter of 0.8–1.2 nm are narrower
than the smallest TiO2 NPs (∼2 nm), thus having a high radius
of curvature, which tends to offer fewer attachment sites for
plasma proteins than larger particles with a lower radius of
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curvature. Fewer opsonins on narrower particles such as
SWNTs mean lower uptake by macrophages, which would
translate to higher SWNT blood circulation times.
Some authors have demonstrated that for particles less than
100 nm, there is minimal to no uptake by the macrophages,
whether they are coated or not by opsonins.118,119 Therefore,
it can be concluded that for particles with a high radius of
curvature and a small size (,100 nm), the outcome is more
promising when compared to larger particles with a low
radius of curvature. This augurs well for SWNTs, which
have an effective diameter of 0.8–1.2 nm and lengths that
vary from 50–150 nm after processing. With such a narrow
diameter and high radius of curvature, it would seem that
SWNTs are ideally suited to escape opsonin binding, without any extraneous functionalization and coating. However,
the length of the SWNT has a propensity to show a lot of
variation, mainly due to the random nature of the shortening process employed. In vivo, shorter CNTs have shown
propensity towards improved biodistribution and effective
clearance through the kidney and liver.42,94,96 Shorter CNTs
(,200 nm) are able to traverse the endothelial cell barrier
through their fenestrae along both axes, which would potentially permit uptake by hepatocytes and excretion through
feces. However, in kidneys, the physiologic pore diameter
is significantly smaller (around 5 nm), therefore permitting
passage of only aligned SWNT, tip first and along the longitudinal axis (Figure 5).

Effect of shape
It has been demonstrated that the shape of NPs plays a
greater role than their size in the process of phagocytosis by
macrophages. Different shapes of polystyrene particles were
synthesized and exposed to macrophages after opsonization
with IgG.115 The Ω-angle was defined as the angle formed
between the point of contact of the cell membrane and the
particle. Phagocytosis was not initiated at Ω .45° for nonspherical particles. Opsonized and nonopsonized particles
had the same Ω dependence.115 This essentially means that
particle internalization is primarily dictated by the shape of
the surface at the point of initial contact. For example, in a
rod-shaped particle, internalization is initiated only if the
tip/end of the rod comes in contact with the cell membrane
of the macrophage, whereas no internalization happens if
the point of contact is the sidewall. In a recent study,120 it
was demonstrated that MWNTs undergo tip-first recognition and entry into cells. Through receptor clustering at
the rounded tube tips, the cells initiate the uptake of the
one-dimensional particles. Interestingly, this was observed
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only in tubes that had closed end caps, and not in open-ended
tubes. Therefore, orientation of the rod prior to interacting
with macrophage will play a great role in determining if
internalization proceeds or not. Spherical particles are not
faced with this complication and, therefore, will more readily undergo internalization. The shape of the SWNT clearly
affords it an advantage in comparison to spherical and ovoid
particles as extraneous and additional factors, such as orientation, do not play any role in their internalization. However,
the orientation of SWNTs is crucial for in vivo clearance,
particularly for shortened SWNTs, when in the glomerulus,
as the small functional pore size of the endothelium-basement
membrane–podocyte complex will only permit passage if the
orientation is along the long axis (Figure 5).94,95

Surface hydrophilicity
Hydrophilicity, when compared to hydrophobicity, is known
to greatly prevent nonspecific adsorption.121 Opsonins, IgG
and complement factors, and plasma proteins in general
adsorb more readily on hydrophobic surfaces than on hydrophilic surfaces (Figure 3).122–124 In vitro and in vivo studies
have also demonstrated higher degrees of phagocytosis and
increased sequestration to hepatic tissue of hydrophobic
particles in comparison to hydrophilic particles.123,125–127 In
order to counteract the attractive hydrophobic forces between
the hydrophobic particle and proteins, polymers such as PEG
are conjugated to hydrophobic surfaces.128 PEG, along with
other similar polymers, are hydrophilic, inert (no net charge),
biocompatible, and elicit no response from plasma proteins.128
The presence of the polymer coating on hydrophobic surfaces
creates a water cloud, which serves as a potential barrier
against plasma proteins by preventing any binding from
occurring, while denying any attachment sites.129 The water
cloud is formed due to the high affinity and linking of two
to three water molecules by each polymer chain.130 The low
attractive forces between the surface and proteins are due to
the creation of minimum interfacial free energy by the water
cloud.129 Besides polymers such as PEG, polysaccharides are
also used, mainly due to their biodegradability.131 Pulmonary
surfactants, such as CUROSURF® (Chiesi Farmaceutici, SpA,
Parma, Italy) are able to nonspecifically bind to CNT and, in
turn, be able to alter the composition of the protein corona as
a result of precoating and altered hydrophobic interactions.132
It is believed that the protein corona decides the fate of the
NP in vivo, and since the composition of the protein corona
is dependent on the hydrophilicity of CNTs, the eventual
fate can be controlled with adequate processing of CNTs.
Even though precoating with polymers and surfactants, and
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rendering the CNT surface as hydrophilic, cannot completely
abolish protein corona formation, it has the propensity to
decrease and alter the protein profile that could enhance
CNT’s in vivo biodistribution and biokinetics.

Surface property and charge
By comparing NPs such as SWNTs, MWNTs, TiO2, ZnO,
SiO2, and quartz sand, Sund et al117 identified that adsorbed
plasma proteins, such as fibrinogen, complement proteins,
Igs, and apolipoproteins, did not vary, and they covered NPs
irrespective of their surface properties. However, the binding
efficiency of these NPs to cell lysate proteins varied based
on surface characteristics. This is attributable to plasma
proteins having glycosylated residues not commonly encountered among cytoplasmic proteins. The formation of protein
coronas around NPs might also likely be due to alterations
in their surface properties due to the pH of the surrounding
environment. TiO2 interacts with proteins more effectively at
pH 6 compared to neutral and near-basic pH values.
Most functional groups have a net charge and, even though
they can independently contribute to the interaction dynamics with plasma proteins and macrophages, we will analyze
them together in this section. Recent investigations using
nanoshells have shown that positively charged particles have
a higher rate of uptake by phagocytic cells in comparison to
negatively charged and neutral particles.133 In another study,
negatively charged PEG–single-walled carbon nanohorns
displayed lower macrophage uptake.134 It is important to note
that the density of the surface coating is equally important in
determining cellular uptake. Different NPs can demonstrate
highly discordant behavior when internalization is purely
analyzed from a charge-based perspective. For example,
recently, in vivo intravital real-time multiphoton microscopy
of the liver revealed that positively charged mesoporous silica
NPs was primarily taken up by hepatocytes, and negatively
charged particles were taken up by phagocytic Kupffer cells
(Figure 5).96 Likewise, a study using polystyrene NPs showed
that negatively charged particles had a higher internalization rate into macrophages, and positively charged particles
into monocytes.135 Highly charged surfaces, in comparison
to neutral particles, attract complement factors. However,
Liu et al136 demonstrated that complement factors are not
activated in the presence of neutral and negatively charged
particles. Patel et al,110 on the other hand, demonstrated that
positively charged particles became negatively charged
in serum after the opsonization process. Experiments on
polystyrene particles functionalized with amine, hydroxyl,
carboxyl, and sulfate groups have demonstrated that amine
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groups, along with hydroxyl groups, activate complement
proteins C3 and C4.113 Also, experiments on thiolated NPs
have revealed shorter plasma half-lives, up to 3 hours, and
preferential uptake by spleen.137 Therefore, the design of
“stealth” NPs should incorporate several parameters that
are important in collectively rendering the NPs transparent
to the phagocytic cells of the RES.

Strategies to shield CNTs
Many strategies that are used to coat CNTs for efficient
in vivo functionality have erupted over the last decade
(Figure 4). While some studies have focused on the interaction of these hybrid CNTs with cells such as macrophages,
lung epithelia, skin fibroblasts, and varied tumor cells at the
cellular level, others have looked at their pharmacokinetics and biodistribution profiles in vivo.62,70,138–146 However,
a majority of these strategies are focused at aiding the
internalization of CNTs into their respective cell types for
imaging and therapy. While this addresses the targeting component of the CNT-based nanoagents, it avoids the issue of
opsonization when the particles are introduced into biofluids.
It is possible that some of these novel coatings could impart
their requisite “stealth” character to the CNTs. This, however, is seldom practiced due to a variety of considerations.
A holistic approach, whereby the manufactured hybrid CNT
nanoagents are tested and validated both for targeting and
long circulation times in vivo, will lead to better assessment
and confidence in their potential.
The strategies used to shield the CNTs can be broadly
divided into noncovalent and covalent (Figure 2). The
noncovalent modality for shielding CNTs have been demonstrated in order to improve blood circulation time and
biodistribution.42,147 A hybrid construct made of lipid and
PEG was used, where the lipid moiety interfaces with the
CNT sidewall through hydrophobic interaction, and PEG
affords improved biodistribution. The report suggests a stable
interaction between the lipid moiety and the CNT surface
throughout the study. This is important since dissociation of
the lipid–PEG construct from the CNT will enable the ready
adsorption of opsonins, along with various plasma proteins,
for recognition and elimination by the RES pathway. However, in a recent study,148 it was shown that MWNTs pretreated
with CUROSURF®, a pulmonary surfactant consisting primarily of PLs, and incubated with blood plasma, underwent
dynamic changes in the lipid coatings. The primary blood
plasma lipids, such as cholesterol and triglycerides, appeared
to bind to the MWNTs, and there was also a low association of
phosphatidylserine (PS), one of the PLs from CUROSURF®.
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In a related study,138 it was demonstrated that SWNTs coated
with PS were recognized by professional macrophages and
internalized through the endocytotic pathway. However, there
was no recognition or uptake of phosphatidylcholine-coated
SWNTs by macrophages. In apoptotic cells, PS is no longer
restricted to the cytoplasmic side of the membrane and is
exposed on the surface to the extracellular medium, thus
enabling recognition by PS-specific receptors present on
macrophages. Taking cues from such natural processes, one
can envisage the development of artificial agents that exploit
this machinery for effective in vivo roles. Can PLs devoid of
PS be used as a potential “stealth” imparting moiety, provided
their stability in an in vivo dynamic environment is reliable?
Even though this concept is significantly compelling, it is
early to conclude that MWNTs pretreated with lipids can
be displaced by plasma lipids, and possibly even proteins,
upon exposure to blood. This phenomenon is reminiscent
of the Vroman effect, which originally described complex
protein adsorption–desorption effects occurring on particle
surfaces.149 Highly mobile proteins such as bovine serum
albumin adsorbed on biopolymer surfaces were observed
to be displaced by less mobile, but high-affinity, proteins
such as fibrinogen. Besides the binding affinity and stability
of the lipophilic interfacing moiety, it is also important to
consider the hydrophilic interfacing group (PEG) that affords
immunity to the CNTs against opsonins. For this, considering
the high aspect ratio of CNTs and other rod-shaped NPs in
general, length, density, and the conformational state of the
polymer moiety plays a significant role in determining the
stealth behavior of CNTs.
Liu et al42 demonstrated that increasing the length of the
linear PEG chain from 2 kDa to 5 kDa increased the blood
residence time from ∼1.2 hours to 5 hours. However, there
was negligible improvement in the blood residence time
when 7 kDa and 12 kDa PEG were used. When branched
7 kDa PEG chains were used, a dramatic increase in the
blood residence time of ∼15 hours was observed.150 Further
studies carried out by Liu et al143 using different densities,
ranging from 5%, 10%, 25%, 50%, and 100% with both
2 kDa and 5 kDa PEG chains, brought about increasing
blood circulation times, up to ∼12.8 hours for 10%–5kDa
PEG to ∼21 hours for 100%–5kDa PEG. This suggests
the effect of increasing linearity and density of polymer
coating on the ability of hybrid CNT constructs to evade
opsonins, thereby improving blood circulation times (Figure
6). Improved density translates to lowering the unoccupied
gaps on the CNT surface that could potentially serve as
attachment sites for opsonins. The biodistribution profile of
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the respective PEG chains demonstrate predominant uptake
by RES organs such as the liver, spleen, and bone marrow,
more so for the linear PEG chains. Long-term fates of the
linear PEG–SWNT constructs in the animals showed that
the majority of them were excreted via the biliary pathway
into the intestine, and eventually through feces. The authors
also alluded to renal excretion among a small percentage of
SWNTs that were below the glomerular excretion threshold
(,50 nm) at 24 hours post-injection. Interestingly, there was
significant accumulation of the long circulating constructs
with half-lives .16 hours, 50%–5kDa PEG and 100%–5kDa
PEG in the skin (∼29% ID/g), which is comparable to tumor
uptake (∼23% ID/g). In contrast, there was relatively lower
uptake of 10%–5kDa PEG with blood circulation times of
∼12.8 hours in the skin (∼3% ID/g), as well as acceptable
tumor uptake (∼15% ID/g). Accumulation of ultra-long
circulating PEG–SWNT in skin is intriguing and presents
unusual challenges that could potentially interfere with
the purported applications such as PT and PA imaging and
therapy, where there is a high probability of interference
from the accumulated dermal SWNT lying in the beam path.
Therefore, it seems that a good balance of optimal circulation times, tumor uptake, and low accumulation in the RES
organs and skin by controlling the length and density of the
polymer coating, will help in achieving a desirable outcome.
However, these studies, have seemingly omitted evaluation
of the biphasic pattern in plasma concentration profile of the
hybrid adducts. Any injectable is eliminated from the blood
through two phases: 1) an initial α-phase, where the injectable
is rapidly distributed to the tissues from the blood, followed
by a pseudo-equilibrium phase where the drug equilibrates
between the blood and tissue compartments; and 2) a gradual
β-phase, where the drug is slowly metabolized and excreted.
This would be helpful in determining the relationship between
the different phases and organ-specific uptake – tumor uptake
in particular.
The pan European groups of Bianco et al14 and Kostarelos
et al151 have spearheaded the biological characterization
and pharmacokinetics of covalently functionalized CNTs
(Figure 2). Ammonium-functionalized CNTs were generated,
to which DTPA, a chelating molecule, was linked to enable
the complexation of γ-emitting radiometals such as 111In.88 The
research groups demonstrated that CNTs functionalized in
this fashion underwent rapid renal clearance, with preferential
accumulation (∼20%) observed in muscle, skin, blood, and kidney, 30 minutes post-injection. This fell to ,1% after 3 hours
and ,0.7% after 24 hours. The blood circulation half-life
was ∼3.5 hours. As seen with the noncovalently-functionalized
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CNTs, the blood circulation half-life was improved by increasing the degree of functionalization through the introduction
of acid-induced surface defects, to which additional DTPA
molecules were linked.152 The initial blood half-life (t1/2) of
the CNTs with a high degree of functionalization measured
0.013 h−1, which demonstrates that the CNTs were distributed
rapidly post-injection. The second phase blood half-life (t1/2β)
measured ∼7 hours. A similar study by Jain et al,8 employing
99mTc-labeled carboxylated MWNTs with different degrees
of functionalization up to ∼3.4 µmol/mg carboxyl density,
was evaluated. MWNTs were subjected to oxidation by acids
for 1 hour, 2 hours, 4 hours, and 6 hours. Higher degrees of
agglomeration of the CNTs was seen in 1-hour- and 2-hourtreated MWNTs, evident by the higher uptake and retention
of these tubes, even after 24 hours, by the RES organs, such
as the liver, spleen, and lungs. However, MWNTs oxidized
for 4 hours and 6 hours, which also had considerable uptake
by the RES organs, were slowly cleared in the span of 2–24
hours. This confirms the predominant role of the degree of
functionalization in improving the density of coverage over
CNTs, thus effectively shielding the entire surface of the rod.
In the past, density and branching of the shielding materials
were shown to be the most important parameters for determining blood circulation (t1/2β) and not length, chemistry, or
architecture.
The ideal blood circulation half-life is application
dependent. For imaging, which requires the particles to accumulate and achieve concentrations in the tissues followed by
clearance, to produce adequate contrast, the optimum t1/2 is 2–6
hours. In comparison, for therapeutic purposes, the optimal
t1/2 is significantly longer to facilitate the repeated pooling of
the particles in the tissue of interest. So far, the PEG-shielded
CNT seems to be the polymer of choice for both imaging and
therapeutics with its longer t1/2, which is in comparison to the
∼7-hour t1/2 of covalently functionalized CNTs. However,
some recent reports have shown that PEG–SWNT hybrids
elicit concentration- and surface density-dependent cytotoxicity in PC12 cells, caused by oxidative stress.153 Another report
suggests that PL–PEG moieties are responsible for complement activation by CNT, triggering the lectin pathway.154
Being one of the most extensively studied and reviewed
molecules, PEG and its interactions with various particles
are being elaborately characterized and reported. This augurs
well for the biomedical community. Likewise, there is a
need for alternative shielding agents that offer comparable,
and sometimes better, efficacy after complexation with the
particles. Pluronic surfactants such as F127 and F108 coated
on MWNT have shown to afford better protection against
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nonspecific serum protein adsorption and anti-inflammatory
processes.140,145 By effectively dispersing MWNTs, F108
passivates the CNT surface by forming a protective brush-like
layer that is able to prevent profibrogenic responses in the
macrophages through steric hindrance and, hence, have little
cellular uptake. Another recently used strategy was to coat
CNTs with a hydrophobic polystyrene polymer (50% w/w).155
A considerable enhancement in the dispersion of polystyrene
coated CNTs and a subsequent reduction in internalization by
macrophages was reported. We also reported a novel strategy
to coat SWNTs with gold to create “golden nanotubes”, which
benefits from the biocompatibility afforded by the surface
gold plating and the complementary NIR absorption properties of the two materials.20 Highly specific localization of
the golden nanotubes was observed in the lymphatic tissues
60 minutes post-injection, with persistence of the significant
PA/PT signal up to 5 hours, indicating good biodistribution
and blood residence time. However, just as was noticed in
PEG, there is an increased risk of adverse reaction against
synthetic materials. Therefore, natural biopolymers such
as saccharides, proteins, and nucleic acids can be deployed
to shield the CNTs. Our group has reported shielding the
SWNTs with dextran sulfate to prevent opsonization by
uniformly coating the SWNT surface in a facile manner to
minimize exposure of the hydrophobic sidewall of the SWNT
to the external milieu.39 We have also demonstrated that there
was minimal internalization of dextran–SWNT constructs by
human macrophages after preincubating with opsonins, C3b,
and Igs.25 Further, there is scope for employing biocompatible
small molecules and proteins such as protein A and factor H
complexes to SWNTs, to mimic common pathogens, such as
Staphylococcus aureus, in evading the immune system.

Conclusion
CNTs represent a unique class of nanomaterials that have
successfully bridged the gap between the biomedical and
material sciences. A range of novel biomedical applications
for CNTs has emerged in the last decade that showcases their
potential for nanotheranostics. Several factors contribute to
the stability and performance of CNTs in living systems,
such as their biocompatibility, surface functionalization,
biodistribution in tissues, and physicochemical characters
including shape, size, and surface property, which were discussed in this review. Given their poor solubility in aqueous
solvents and in their native aggregated state, processing
strategies, such as coating with shielding agents or chemical
treatment to modify the surface, is commonly practiced.
Some of the widely used strategies include PEGylation,
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covalent functionalization with charged groups, and passivation through surfactants. Considerable improvement has been
made in enhancing the blood circulation half-life and biodistribution of the hybrid CNT constructs. To date, PEGylated
CNTs have demonstrated the maximal blood residence time
(∼21 hours) in comparison to covalently functionalized CNTs
(∼7 hours). The two routes of excretion have been distinctly
delineated based on the shielding strategies: noncovalent,
namely through the hepato–biliary system; and covalent,
through the renal system.
However, there still is a need for alternative shielding
strategies that can provide not only stealth character to the
CNTs, but also additional “smart” functionality. In our
opinion, novel shielding agents should provide “smart”
functionality to the CNT constructs in addition to their usual
property of increasing blood residence time. Additional
conjugation sites for improving the stoichiometry and the
loading density of ligands, their modularity to incorporate
a wide variety of functionalization strategies, and their pH
and oxygen sensitivity, are some of the desired properties
to render CNT-based theranostic nanoagents as multimodal
and semiautonomous. There, however, are many pertinent
health-related challenges that need to be overcome before
approaching the subject of real clinical translation, such as
persistence in the tissues, elimination, and the long-term
after-effects of CNTs. Interestingly, there are encouraging
reports towards realizing the complete degradation and
elimination of CNTs in vitro and in cellulo. Emerging
evidence shows that catalytic enzymes such as horseradish
peroxidase are able to degrade carboxylated CNTs in the
presence of hydrogen peroxide.100 This would, however,
require that the CNTs are eventually localized in the acidic
environments of the endosomes over prolonged periods of
time for complete degradation. Kagan et al99 have reported
biodegradation of CNTs in cellulo, occurring in neutrophils
with the help of a neutrophil enzyme, MPO. When aspirated
into the lungs of mice, the degraded CNTs failed to elicit
an inflammatory response, suggesting the benign nature of
the degraded byproducts. Perhaps future coating strategies
can exploit this unique biodegradation pathway available
in the form of polymorphonuclear cells, and the associated
catalytic enzymes, through selective uptake. This, however,
should ideally occur during the clearance phase of CNT
biodistribution in order to prevent early sequestration,
degradation, and excretion before its intended purpose is
realized. If semi-autonomous multimodal theranostic CNTbased nanoagents are envisaged, true hybrid constructs
that take advantage of biological cues and natural systems
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should be designed. For example, the fates of foreign NPs
and their hybrid nanoconstructs in vivo depend upon their
physicobiochemical properties, including their size, shape,
and surface chemistry. Some novel approaches have been
reported to engineer NPs and their architectures with desirable size, shape, and functionality, including those based
on the “nanotoolbox”-based programmable self-assembly
approach developed by our group.2,3,156,157 The capability
of modulating the geometric configurations and surface
characteristics suggests opportunities to overcome the
hurdle, while considerably increasing blood circulation
times as well as biocompatibility.128,129 There exist many
biological particles, such as blood cells and pathogenic
bacteria, that have evolved to evade macrophages by being
transparent to the blood opsonins. Using lessons from
nature, the design and construction of nanostructures with
particular shapes and surface characteristics may permit
us to avoid opsonization and premature clearance of
nanotheranostics,2,3 enabling realization of NP-based theranostics and their translation into clinical practice. Finally, as
the technology progresses, appealing new directions would
arise that could transform the field of nanomedicine beyond
those described in this review.
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